Hypoxic Cancer Cells Protect Themselves Against Damage: Search for a Single-Cell Indicator of This Protective Response_Crimson Publishers

 

Hypoxic Cancer Cells Protect Themselves Against Damage: Search for a Single-Cell Indicator of This Protective Response by Polina Schwartsburd in Novel Approaches in Cancer Study


Abstract

Tumor hypoxia is accompanied by resistance to many damaging therapeutic effects. This effect is often attributed to the loss of the ability of normal and benign tumor cells to adapt their metabolism to hypoxia, whereas cancer cells, on the contrary, acquire the ability to survive and avoid an immune response under hypoxic conditions. Moreover, cancer cells use hypoxia to reprogram their metabolism and induce antioxidant protection, in particular by increasing the production of antioxidant molecules [NAD(P)H and glutathione], which protect hypoxic cancer cells from the damaging effects of free radicals. However, hypoxic cancer cells may differ one from another by the efficiency of protection against damage; an indicator is required to assess this efficiency. The goal of our work is the search for such a single-cell endogenous indicator. For this, we measured endogenous NAD(P)H fluorescence in single hypoxic cancer cells during their UV-induced damage [NAD(P)H photodegradation], as well as determined their ability to restore NAD(P)H fluorescence intensity after the damage/(photo)degradation. Most hypoxic cancer (but not normal) cells were experimentally found to be capable of partially restoring the damage with different efficiencies. Some hypoxic cancer cells possess increased resistance to UV-induced damage. Such cells retained the ability to partially restore NAD(P)H intensity even after 5-6 cycles of repeated damage. Our studies enable recommending the NAD(P)H regenerative response observed in hypoxic tumor cells as a prognostic indicator to assess their potential resistance to damage. This indicator can be useful in choosing new antitumor capabilities of specifically destroying cancer cells with increased resistance to damage.

Read more about this article:

For more articles in Novel Approaches in Cancer Study

https://crimsonpublishers.com/nacs/


Comments

Post a Comment

Popular posts from this blog

Recent Advances in the Therapeutic Approaches of Glioblastoma Multiforme_Crimson Publishers

Image
  Recent Advances in the Therapeutic Approaches of Glioblastoma Multiforme by Siddharth Shah in  in Novel Approaches in Cancer Study Abstract Glioblastoma Multiforme (GBM, WHO grade IV) is one of the most aggressive, invasive, and lethal intracranial neoplasms, with a low post-diagnosis survival rate. Standard-of-care treatment regimens involving maximal surgical resection, radiotherapy, and genetic anti-tumor compounds like Temozolomide have only been marginally effective in improving overall survival and quality of life. Cell fusion, autophagy, and other complex biological processes affecting GBM pathophysiology are being studied to improve GBM treatment. This paper therefore focuses on oncolytic virus therapy combined with surgical resection, photodynamic therapy, and novel gene therapy, demonstrating how GBM treatment for patients could result in immediate and authentic tumor cytotoxicity and removal, rather than treatment of recurrent GBM. Standard therapy for GBM,...
Read more

Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases

Abstract Inorganic phosphate (Pi) is essential for several biochemical reaction. Serum Pi is maintained at relatively narrow range concentrations, between 0.7 and 1.55mM. Tumor microenvironment presents a high Pi concentration (1.8±0.2mM Pi) and this could be associated wi the rapid growth in the “Growth Rate Hypothesis”. Several studies have identified high expression of Pi transporters in various tumor tissues. Similarly, ecto-enzymes (like ecto-nucleotidases or ecto- phosphates) act by dephosphorylating phosphosubstrates in the extracellular environment, and its high expression has been observed in various types of cancer. Little is known about the function of these ecto-enzymes on Pi releasing and accumulation in the tumor environment. Therefore, the purpose of this study is to correlate a possible contribution of the Pi release in the tumor microenvironment by ecto-nucleotidases and ecto-phosphatases, concomitant to the regulation of Pi extracellular pool by specific Pi...
Read more

Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases_Crimson Publishers

Image
Release of Inorganic Phosphate into the Tumor Environment: Possible Roles of Ecto- Nucleotidases and Ecto-Phosphatases by Marco Antonio Lacerda-Abreu and José Roberto Meyer- Fernandes in Journal of Cancer Research Crimson Publishers _  Novel Approaches in Cancer Study Inorganic phosphate (Pi) is essential for several biochemical reaction. Serum Pi is maintained at relatively narrow range concentrations, between 0.7 and 1.55mM. Tumor microenvironment presents a high Pi concentration (1.8±0.2mM Pi) and this could be associated wi the rapid growth in the “Growth Rate Hypothesis”. Several studies have identified high expression of Pi transporters in various tumor tissues. Similarly, ecto-enzymes (like ecto-nucleotidases or ecto- phosphates) act by dephosphorylating phosphosubstrates in the extracellular environment, and its high expression has been observed in various types of cancer. Little is known about the function of these ecto-enzymes on Pi releasing and accumulation in the tu...
Read more